Increased renal semicarbazide-sensitive amine oxidase activity and methylglyoxal levels in aristolochic acid-induced nephrotoxicity

Aims

Aristolochic acid (AA) nephrotoxicity is related to accumulation of methylglyoxal (MGO) and N^ε-(carboxymethyl)lysine (CML) in the mouse kidney. We studied the activity of renal semicarbazide-sensitive amine oxidase (SSAO), a key enzyme involved in MGO generation, in AA-treated mice, and investigated nephroprotective effects produced by metformin, a MGO scavenger.

Methods

Mice were orally administered water or metformin for 15 days (12 or 24 mg kg^− 1 day^− 1), and injected AA (5 mg kg^− 1 day^− 1) intraperitoneally for 8 days starting on day 8. Renal function was studied, and histopathological examination, determination of renal SSAO activity, and measurement of MGO levels were performed.

Key findings

Compared to control mice, AA-injected mice showed significant renal damage and approximately 2.7-fold greater renal SSAO activity (p < 0.05). Further, compared to control treatment, administration of 12 mg/kg metformin inhibited formation of renal lesions, and significantly decreased renal MGO levels (37.33 ± 9.78 vs. 5.89 ± 2.64 μg/mg of protein, respectively, p < 0.01). In the AA-treated mice, metformin also inhibited the accumulation of CML in renal tubules, but did not affect SSAO activity.

Significance

This study is the first to show elevated renal SSAO activity in AA-treated mice, which could be involved in MGO accumulation. Moreover, MGO scavenging by metformin reduces AA nephrotoxicity. These findings suggest that reducing MGO accumulation produces nephroprotection, revealing new therapeutic strategies for the management. SSAO is a key enzyme involved in MGO generation, and consequently, inhibition of renal SSAO activity is worth investigating in AA nephrotoxicity and other renal pathologies further.     

The end product of transglutaminase crosslinking: Simultaneous quantitation of [N-(γ-glutamyl) lysine] and lysine by HPLC-MS

Transglutaminases catalyze the formation of N^ε-(γ-glutamyl) isodipeptide crosslinks between proteins. These enzymes are thought to participate in a number of diseases, including neurological disease and cancer. A method associating liquid chromatography and multiple stage mass spectrometry has been developed for the simultaneous quantitation of [N^ε-(γ-glutamyl) lysine] isodipeptide and lysine on an ion trap mass spectrometer. Highly specific detection has been achieved in MS³ mode. The method includes a derivatization step consisting of butylation of carboxylic groups and acetylation of amide groups, a liquid-liquid extraction, and a 19-min separation on a 100 × 2.1-mm Beta-basic C₁₈ column with an acetonitrile gradient elution. ¹³C₆-¹⁵N₂ isotopes of the isodipeptide and the lysine serve as internal standards. The assay was linear in the range of 50 pmol/ml to 75 nmol/ml for the isodipeptide and the range of 10 nmol/ml to 3.5 μmol/ml for the lysine, with correlation coefficients greater than 0.99 for both ions. Intra- and inter-day coefficients of variation ranged from 3.5 to 15.9%. The method was successfully applied to human biological samples known to be crosslinked by transglutaminase such as cornified envelopes of epidermis, fibrin, and normal and Huntington disease brain.     

Structural and magnetic characterization of a novel series of dinuclear Cu(II) complexes bridging by 2,5-pyrazine dicarboxylate

A new series of dinuclear 2,5-pyrazine dicarboxylato-bridged copper(II) complexes were synthesized and characterized by spectroscopic techniques. The complexes have the general structural formula [Cu₂(L)₂(μ-pyzdc)](ClO₄)₂·nH₂O where L = TPA, n = 2 (1); L = pmedien, n = 2 (2); L = aepn, n = 3 (3); L = dpt, n = 2 (4); L = Medpt, n = 0 (5); L = dien, n = 0 (6) and L = MeDPA, n = 2 (7) with TPA = tris(2-pyridylmethyl)amine, pmdien = N,N,N′,N′′,N′′-pentamethyldiethylenetriamine, aepn = N-(2-aminoethyl)-1,3-diaminopropane, dpt = dipropylene-triamine, Medpt = 3,3′-diamino-N-methyldipropylamine, dien = diethylenetriamine, MeDPA = N,N-di(2-pyridylmethyl)methylamine. In these complexes, the bridging nature of the 2,5-pyrazine dicarboxylato ligand (pyzdc) was confirmed by single-crystal X-ray crystallography. The structure of the TPA complex 1 consists of μ-pyzdc bridging two Cu(II) centers in a bis(monodentate) bonding fashion through a single oxygen atom supplied by each carboxylate group of the bridged pyzdc in a distorted trigonal bipyramidal geometry achieved by the four nitrogen atoms from the TPA ligand. In the complexes 2-5 derived from tridentate amines, the bridged pyzdc acts as a bis(bidentate) ligand in a distorted square pyramidal geometry achieved by one nitrogen and one carboxylate-oxygen of pyzdc, and by the three N-atoms of the amine coligands. The intradimer Cu?Cu distances in the complexes 2-5 are in the range 6.97-7.45 ? and in it is 10.96 ? in 1. The corresponding intermolecular distances are even shorter (5.34-7.99 ?). The susceptibility measurements at variable temperatures over the 5-300 K range reveal weak antiferromagnetic coupling with J values ranging from −0.61 to −4.78 cm⁻¹.     

Structural and magnetic characteristics of tetramethylammonium tetrahalogenoferrates(III)

A series of tetramethylammonium tetrahalogenoferrates(III), [FeBr_4−nCl_n]⁻ (n = 0, 1, 3, 4), of general formula [(CH₃)₄N][FeBr_4−nCl_n], have been synthesized. The crystal and molecular structures of [(CH₃)₄N][FeCl₄] were determined. The compound is isostructural with its [FeBr_4−nCl_n]⁻ (n = 0, 1, 3, 4) analogues. Magnetic measurements of the powdered samples of [(CH₃)₄N][FeBr_4−nCl_n] gave negative values of the Weiss constant, which suggest antiferromagnetic coupling. The strength of the antiferromagnetic interactions strongly depends on the kind of halide ligands in the coordination sphere of iron(III) and increases with an increasing number of the bromide anions.     

Investigation of the cumulative tissue doses of naphthoquinones in human serum using protein adducts as biomarker of exposure

Both 1,2-naphthoquinone (1,2-NPQ) and 1,4-naphthoquinone (1,4-NPQ) are reactive metabolites of naphthalene that are thought to be responsible for the naphthalene-induced cytotoxicity and genotoxicity. The aim of this study was to investigate the cumulative tissue dose of 1,2-NPQ and 1,4-NPQ in human serum derived from blood donors in Taiwan via measurements of albumin adducts by a methodology, which employs trifluoroacetic acid anhydride and methanesulfonic acid to selectively cleave cysteinyl adducts on proteins. Both 1,2-NPQ and 1,4-NPQ adducts were detected in all male and female subjects (n = 22). The median levels of 1,2-NPQ adduct in human subjects were estimated to be 268 (range 139-857) and 203 (range 128-1352) (pmol/g) in male (n = 11) and female (n = 11) subjects, respectively. In contrast, the median levels of 1,4-NPQ adduct were estimated to be 45.0 (range 22.0-117) and 38.9 (range 21.5-172) (pmol/g) in male and female subjects, respectively. We noticed that levels of 1,2-NPQ adduct were significantly correlated with those of 1,4-NPQ adduct (correlation coefficient r = 0.643, p < 0.01). Results from in vitro experiments confirmed that the production of naphthoquinones-derived adducts on serum albumin increased with increased concentration of naphthoquinones (0-100 μM). Linear relationships were observed over the range of concentration. Time-course experiments suggested that both 1,2-NPQ and 1,4-NPQ-derived adducts rapidly reached maximum values at 10 min mark and remained constant thereafter. The reaction rate constant analyses indicated that the second-order rate constants, representing in vitro reactions between naphthoquinones and cysteine residues of serum albumin, were estimated to be 0.0044/0.0002 L(g protein)⁻¹ h⁻¹, respectively. Overall, the cumulative tissue doses of 1,4-NPQ (217-316 nM h) in male and female subjects were ∼3-fold greater than those of 1,2-NPQ (76-98 nM h) in the study population. The initial concentrations of serum 1,2-NPQ and 1,4-NPQ in the study population were estimated to be between 145-188 and 807-1175 nM, respectively. We conclude that the relatively large amounts of naphthoquinones present in human serum may point to toxicological consequences.     

Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice

A wide range of protein acyl modifications has been identified on enzymes across various metabolic processes; however, the impact of these modifications remains poorly understood. Protein glutarylation is a recently identified modification that can be nonenzymatically driven by glutaryl-CoA. In mammalian systems, this unique metabolite is only produced in the lysine and tryptophan oxidative pathways. To better understand the biology of protein glutarylation, we studied the relationship between enzymes within the lysine/tryptophan catabolic pathways, protein glutarylation, and regulation by the deglutarylating enzyme sirtuin 5 (SIRT5). Here, we identify glutarylation on the lysine oxidation pathway enzyme glutaryl-CoA dehydrogenase (GCDH) and show increased GCDH glutarylation when glutaryl-CoA production is stimulated by lysine catabolism. Our data reveal that glutarylation of GCDH impacts its function, ultimately decreasing lysine oxidation. We also demonstrate the ability of SIRT5 to deglutarylate GCDH, restoring its enzymatic activity. Finally, metabolomic and bioinformatic analyses indicate an expanded role for SIRT5 in regulating amino acid metabolism. Together, these data support a feedback loop model within the lysine/tryptophan oxidation pathway in which glutaryl-CoA is produced, in turn inhibiting GCDH function via glutaryl modification of GCDH lysine residues and can be relieved by SIRT5 deacylation activity.     

Synthesis, structure and dielectric properties of the 2D K-tetrazole complex [K2(4-TPA)2(H2O)2]n

The 2-D K(I)-tetrazole metal-organic complex, [K₂(4-TPA)₂(H₂O)₂]_n (1), which is constructed by the [K₂O₄N]_n inorganic skeleton chains bridged by the 4-TPA linkers, has been synthesized and characterized by single crystal X-ray crystallography and temperature-dependence dielectric constant(ε) measurement under the alternating electric field, (4-TPA = 2-(4-(1H-tetrazol-5-yl)pyridinium-1-yl) acetate). The ε of temperature dependence remains unchanged almost within the measured temperature range of 90 K to 430 K at 1 M Hz, and the ε of frequency dependence shows a significant decline from 6.7 to 4.6 within the measured frequency range of 200-1 MHz at room temperature. And it is consistent with the low dielectric loss (ε₂/ε₁) behavior, which is attributed to the highly ordered polarization mechanism.     

Photochemical and photophysical properties of ruthenium(II) bis-bipyridine bis-nitrile complexes: Photolability

The electrochemical and photophysical properties of two bis-nitrilo ruthenium(II) complexes formulated as [Ru(bpy)₂(L)₂](PF₆)₂, where bpy is 2,2′-bipyridine and L is AN = CH₃CN and sn = NC-CH₂CH₂-CN, have been investigated. Electrochemical data are typical of Ru-bpy complexes with two reversible reduction peaks located near −1.3 and −1.6 V assigned to each bipyridine ligand and one Ru^II/Ru^III oxidation wave centered at approximately +1.5 V. The sn derivative is both IR and Raman active with its coordinated CN stretch appearing at 2277 cm⁻¹ and 2273 cm⁻¹, respectively. The UV/Vis absorption spectrum of the sn derivative is dominated by an intense (ε_max ∼ 58700 M⁻¹ cm⁻¹) absorption band at 287 nm assigned as a LC (π → π∗) transition. The peak observed at 418 nm (ε ∼ 10 400 M⁻¹ cm⁻¹) is an MLCT band while the one at 244 nm (ε ∼ 23 600 M⁻¹ cm⁻¹) is of LMLCT character. The AN derivative behaves similarly. Both complexes show low-temperature emission at around 537 nm with a lifetime near 10.0 μs. ¹H and ¹³C assignments are consistent with the formulation of the complexes. The complexes undergo photosubstitution of solvent with quantum efficiencies near one. Calculated and experimental results support replacement of the nitrile ligands by solvent. Based on DFT calculations, the electron density of the HOMO lies on the metal center, the bipyridine ligands and the nitrile ligands and electron density of the LUMO resides primarily on the bipyridine ligands. The electronic spectra obtained from TDDFT calculations closely match the experimental ones.     

Chemical and immunochemical identification of propanoyllysine derived from oxidized n-3 polyunsaturated fatty acid

It is known that n-3 polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid and eicosapentaenoic acid, are rapidly oxidized in vitro. N?-(propanoyl)lysine (propionyllysine, or PRL) is formed from the reaction of the oxidized products of n-3 PUFAs and lysine. To evaluate the oxidized n-3 PUFA-derived protein modifications in vivo, we have developed detection methods using a novel monoclonal antibody against PRL as well as liquid chromatography–mass spectrometry (LC/MS/MS). The antibody obtained specifically recognized PRL. A strong positive staining in atherosclerotic lesions of hypercholesterolemic rabbits was observed. We have also simultaneously identified and quantified both urinary PRL and urinary N?-(hexanoyl)lysine, using LC/MS/MS using isotope dilution methods. The level of urinary PRL (21.6 ± 10.6 μmol/mol of creatinine) significantly correlated with the other oxidative stress markers, 8-oxo-deoxyguanosine, dityrosine, and isoprostanes. The increase in the excretion of amide adducts into the urine of diabetic patients was also confirmed compared to healthy subjects. These results suggest that PRL may be good marker for n-3 PUFA-derived oxidative stress in vivo.     

Impact of feeding and starvation on the lipid metabolism of the Arctic pteropod Clione limacina

Feeding and starvation experiments were carried out with Clione limacina sampled in Kongsfjorden (Svalbard, Arctic) during summer 2002. Dry mass and lipid mass, lipid class and fatty acid compositions were analysed. Specimens of C. limacina used for the feeding study had a mean length of 25 mm, a dry mass (DM) of 13.7 mg, and a moderate lipid content of 12.1%DM. Animals were allowed to ingest only one individual of its exclusive prey, Limacina helicina which had 8.0 mm in diameter, 21.4 mg DM and 8.7% lipid of ash-free DM. Five days after feeding, the dry mass of C. limacina had increased from 13.7 to 25.3 mg which corresponds to an uptake of about 80% of the ash-free DM (14.3 mg) of L. helicina. Lipid mass increased from 1.5 to 3.9 mg which is almost two times more the ingested lipid from L. helicina (1.2 mg lipid). Thus, the major portion of lipids was synthesised de novo by C. limacina from non-lipid compounds. These lipids were triacylglycerols (TAG) and 1-O-alkyldiacylglycerol ethers (DAGE), increasing from low proportions of 6.1% and 5.7% to 42.3% and 25.8%, respectively. Considerable de novo synthesis was observed for the monounsaturated fatty acids 16:1(n − 7), 17:1(n − 8), 18:1(n − 9), and 18:1(n − 7) and the alkyl moiety 16:0. The increase in the polyunsaturated fatty acids 22:6(n − 3), 20:5(n − 3), and 18:4(n − 3) corresponded with the amount available by ingestion of L. helicina, supporting that C. limacina is not able to synthesise polyunsaturates. After 15 days of digestion, dry mass and lipids dropped almost back to the initial values.During the 100-day starvation experiment, two groups of animals were separately considered as storage lipid-rich and lipid-poor animals because of their large differences in the amount and proportion of TAG and DAGE. Storage lipid-rich C. limacina were only found until day 50, whereas lipid-poor animals were present throughout the experiment. In the lipid-rich specimens, the levels of TAG were about twice that of DAGE. The proportions of TAG decreased considerably during the 50 days of starvation (from 48.3% to 25.1% of total lipid). DAGE, varying between 16.5% and 20.5%, showed only a small decrease. The lipid-poor animals survived 100 days of starvation, exhibiting low initial amounts and proportions of storage lipids which were nearly exhausted at the end. In all C. limacina specimens, the total lipid content remained almost constant showing that lipid and non-lipid components were simultaneously utilised. This implies that body shrinkage may be an important adaptation to long-term starvation. Based on these results, it is possible to estimate the potential survival period of lipid-rich C. limacina under food limitation. A model, which considers maturity and reproduction (egg production), reveals that lipid-rich specimens might be able to survive up to 260 days without food.     

Insight into hypoxic preconditioning and ischemic injury through determination of nPKCε-interacting proteins in mouse brain

Cerebral hypoxic preconditioning (HPC) provides neuroprotection by intracellular signaling pathways. We previously demonstrated that novel protein kinase Cε (nPKCε) activation participated in cerebral HPC development. In this study, we explore the role of nPKCε in HPC-induced neuroprotection against middle cerebral artery occlusion (MCAO)-induced ischemic injury and identify its possible signaling molecules. A total of 131 adult male BALB/c mice were divided into eight groups: normoxic control (n = 9), HPC (n = 9), HPC + εV1–2 (n = 13), Sham (n = 19), HPC + sham (n = 6), Ischemia (I, 6 h MCAO, n = 31), HPC + I (n = 25) and HPC + εV1–2 + I (n = 19). nPKCε specific inhibitor εV1–2 was administered via intracerebroventricular injection. Western blot, 2,3,5-triphenyltetrazolium chloride staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling were applied to determine nPKCε membrane translocation, infarction volume and programmed cell death (PCD), respectively. Two-dimensional gel electrophoresis (2-De) and matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) were used to identify nPKCε-interacting proteins, followed by bioinformatics analysis of genee ontology (GO) to predict nPKCε-specific signaling pathways. Our results showed that HPC attenuates MCAO-induced brain injuries and stabilized nPKCεmembrane translocation in peri-infarct region, which was abolished by nPKCε-speecific inhibitor εV1–2. Proteomics analysis revealed 8 up- and 3 down-regulated nPKCε-interacting proteins both in cytosolic and particulate fractions of HPC mouse brain. GO analysis predicted 25 significant nPKCε-specific signaling pathways among the 16 identified nPKCε-interacting proteins in brain of HPC mice. This study is the first to report multiple nPKCε-interacting proteins and their signaling pathways in HPC mouse brain, suggesting that nPKCε signaling molecules is responsible for HPC-induced neuroprotection against cerebral ischemic injuries of mice.     

Polyunsaturated fatty acids inhibit stimulated coupling between the ER Ca sensor STIM1 and the Ca channel protein Orai1 in a process that correlates with inhibition of stimulated STIM1 oligomerization

Polyunsaturated fatty acids (PUFAs) have been found to be effective inhibitors of cell signaling in numerous contexts, and we find that acute addition of micromolar PUFAs such as linoleic acid effectively inhibit of Ca^2 + responses in mast cells stimulated by antigen-mediated crosslinking of FcεRI or by the SERCA pump inhibitor, thapsigargin. In contrast, the saturated fatty acid, stearic acid, with the same carbon chain length as linoleic acid does not inhibit these responses. Consistent with this inhibition of store-operated Ca^2 + entry (SOCE), linoleic acid inhibits antigen-stimulated granule exocytosis to a similar extent. Using the fluorescently labeled plasma membrane Ca^2 + channel protein, AcGFP–Orai1, together with the labeled ER Ca^2 + sensor protein, STIM1–mRFP, we monitor stimulated coupling of these proteins that is essential for SOCE with a novel spectrofluorimetric resonance energy transfer method. We find effective inhibition of this stimulated coupling by linoleic acid that accounts for the inhibition of SOCE. Moreover, we find that linoleic acid induces some STIM1–STIM1 association, while inhibiting stimulated STIM1 oligomerization that precedes STIM1–Orai1 coupling. We hypothesize that linoleic acid and related PUFAs inhibit STIM1–Orai1 coupling by a mechanism that involves perturbation of ER membrane structure, possibly by disrupting electrostatic interactions important in STIM1 oligomerization. Thisarticle is part of a Special Issue entitled Tools to study lipid functions.     

Equilibrium and structural studies on Co(II), Ni(II), Cu(II) and Zn(II) complexes with N-(2-benzimidazolyl)methyliminodiacetic acid: crystal structures of Ni(II) and Cu(II) complexes

Combined pH-metric, UV-Vis, ¹H NMR and EPR spectral investigations on the complex formation of M(II) ions (M=Co, Ni, Cu and Zn) with N-(2-benzimidazolyl)methyliminodiacetic acid (H₂bzimida, hereafter H₂L) in aqueous solution at a fixed ionic strength, I=10⁻¹ mol dm⁻³, at 25 ± 1 °C indicate the formation of M(L), M(H₋₁L)⁻ and M₂(H₋₁L)⁺ complexes. Proton-ligand and metal-ligand constants and the complex formation equilibria have been elucidated. Solid complexes, [M(L)(H₂O)₂] · nH₂O (n=1 for M = Co and Zn, n=2 for M = Ni) and {Cu (μ-L) · 4H₂O}_n, have been isolated and characterized by elemental analysis, spectral, conductance and magnetic measurements and thermal studies. Structures of [Ni(L)(H₂O)₂] · 2H₂O and {Cu(μ-L) · 4H₂O}_n have been determined by single crystal X-ray diffraction. The nickel(II) complex exists in a distorted octahedral environment in which the metal ion is coordinated by the two carboxylate O atoms, the amino-N atom of the iminodiacetate moiety and the pyridine type N-atom of the benzimidazole moiety. Two aqua O atoms function as fifth and sixth donor atoms. The copper(II) complex is made up of interpenetrating polymeric chains of antiferromagnetically coupled Cu(II) ions linked by carboxylato bridges in syn-anti (apical-equatorial) bonding mode and stabilized via interchain hydrogen bonds and π-π stacking interactions.     

Copper(II) complexes with 2-N-(picolinylidene)-n-R-phenols: Solvatochromism, self-assembly and supramolecular structures

A series of copper(II) complexes having the formula [Cu(n-R-pyp)X] with the N,N,O-donor Schiff base system 2-N-(picolinylidene)-n-R-phenol (n-R-Hpyp) (where n = 3, 4, 5 and 6, when R = Me and n = 4 when R = Cl) and halide (X⁻ = Cl⁻ or Br⁻) as an ancillary ligand have been synthesized. The complexes are characterized by microanalytical, magnetic and various spectroscopic measurements. They display solvatochromic behavior. Single crystal X-ray structures of all the complexes are determined. In coordinatively unsaturated species such as a square-planar complex, the metal ion can interact with a fifth atom and if this atom is metal bound, dimeric or polymeric aggregate is formed. In the present series of complexes, the metal ions are square-planar and distorted square-pyramidal when there is an intermolecular Cu···X interaction. In addition to this Cu···X interaction, presence of intermolecular weak non-covalent interactions namely O-H···O, C-H···O, C-H···X and π···π are perceived. The supramolecular architectures formed by the molecules of these complexes via these interactions are scrutinized. The observed supramolecular structural motifs can be classified as staircase, ladder, brick-wall and square-grid. Except for R = Cl the analogous chloride and bromide coordinated complexes show similar structural features.     

Structure and characterization of a μ-phenoxo-bis μ-acetato dinuclear Mn(II,II) complex [Mn2(LO)(μ-OAc)2](ClO4) (LOH = 2,6-bis{bis(2-(2-pyridyl)ethyl)aminomethyl}-4-methylphenol): Substituent effects

The synthesis, structure and characterization of the dinuclear Mn(II) complex [Mn₂(LO)(μ-OAc)₂](ClO₄) (1) where LOH = 2,6-bis{bis(2-(2-pyridyl)ethyl)aminomethyl)}-4-methylphenol are reported. The reaction of Mn(ClO₄)₂ · 6H₂O with the dinucleating ligand LOH and H₃CCOONa in the presence of NEt₃ in dry, degassed methanol and under an argon atmosphere, yields 1 as a colorless powder. The crystal structure of 1, determined by X-ray diffraction methods, shows a dinuclear Mn(II) complex in which two Mn(II) ions, each in six-coordinate approximate octahedral coordination, are bridged by the phenolate oxygen of LO⁻ and by two acetate ions in a syn,syn-1,3-bridging mode. The Mn-Mn distance is 3.557(1) Å and Mn-O_phenolate-Mn angle is 112.50(9)°. Cyclic voltammetry of 1 in acetonitrile solution shows a quasi-reversible wave at E_1/2 = 0.65 V, for the Mn₂(II,II)/Mn₂(II,III) redox process, and an irreversible oxidation peak at E_p,c = 1.22 V versus Ag/AgCl for the Mn₂(II,III) to Mn₂(III,III) oxidation process. Controlled potential electrolysis of 1 in acetonitrile solution at 0.85 V (versus Ag/AgCl) takes up 1 F of charge per mole of 1 to yield a brown solution of the Mn₂(II,III) state of the complex, which, however, is unstable and reverts back to the Mn₂(II,II) state in solution at room temperature. Least square fitting of the variable temperature magnetic susceptibility measurements on powdered sample of 1 is obtained with g = 1.888, J = −2.75 cm⁻¹, Par = 0.008, TIP = 0. The low −J value and the room temperature calculated magnetic moment of the complex (5.30 BM per Mn(II)), which is less than the spin-only moment of Mn(II), show that the two Mn(II) ions are weakly antiferromagnetically coupled.     

Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease

Monoamine oxidases (MAO) and cholinesterases are validated targets in the design of drugs for the treatment of Alzheimer's disease. The multi-target compound N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (ASS234), bearing the MAO-inhibiting propargyl group attached to a donepezil moiety that inhibits cholinesterases, retained activity against human acetyl- and butyryl-cholinesterases. The inhibition of MAO A and MAO B by ASS234 was characterized and compared to other known MAO inhibitors. ASS234 was almost as effective as clorgyline (k_inact/K_I = 3 × 10⁶ min^− 1 M^− 1) and was shown by structural studies to form the same N5 covalent adduct with the FAD cofactor.     

Homogeneous oxidative coupling catalysts. Mechanism of catalysts formation by oxidation of [(Pip)nCuX]4 (n = 1 or 2, Pip = piperidine, X = Cl, Br or I) by dioxygen in aprotic media

This paper reports the mechanism of formation of oxidative coupling catalysts [(Pip)_nCuX]₄O₂, n = 1 or 2 and X = Cl, Br or I, which represent half of the catalytical cycle, Scheme 1. The mechanism has been described as a pre-equilibrium between [(Pip)_nCuX]₄ and O₂. K values are very sensitive to how strong the hydrogen-bonding between copper (I) tetranuclear and incoming dioxygen is, such association is also sensitive to the variation of X. The pronounced pre-equilibrium is the reason behind the oxidation of [(Pip)_nCuI]₄, which is not the case for pyridine type of ligands. The pre-equilibrium followed by rate determining step k₂, which is responsible to the formation of the oxidative coupling catalysts [(Pip)_nCuX]₄O₂. The overall reaction is a second-order process, first order in each [[(Pip)_nCuX]₄] and [O₂], with rate constant k_on (k_on = Kk₂) and exothermic ΔH^≠ varying from −3 to −12 kcal mol⁻¹ and ΔS^≠ varying from −87 to −65 cal deg⁻¹ mol⁻¹. k_on were found to be very sensitive to n value 1 or 2 and to the type of X (Cl, Br or I).     

Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification.

The objectives of this study were to estimate the structure of the lipid hydroperoxide-modified lysine residue and to prove the presence of the adducts in vivo. The reaction of lipid hydroperoxide toward the lysine moiety was investigated employing N-benzoyl-glycyl-L-lysine (Bz-Gly-Lys) as a model compound of Lys residues in protein and 13-hydroperoxyoctadecadienoic acid (13-HPODE) as a model of the lipid hydroperoxides. One of the products, compound X, was isolated from the reaction mixture of 13-HPODE and Bz-Gly-Lys and was then identified as N-benzoyl-glycyl-Nepsilon-(hexanonyl)lysine. To prove the formation of Nepsilon-(hexanonyl)lysine, named HEL, in protein exposed to the lipid hydroperoxide, the antibody to the synthetic hexanonyl protein was prepared and then characterized in detail. Using the anti-HEL antibody, the presence of HEL in the lipid hydroperoxide-modified proteins and oxidized LDL was confirmed. Furthermore, the positive staining by anti-HEL antibody was observed in human atherosclerotic lesions using an immunohistochemical technique. The amide-type adduct may be a useful marker for the lipid hydroperoxide-derived modification of biomolecules.     

n − 3, but not n − 6 lipid particle uptake requires cell surface anchoring

Omega-3 (n − 3) fatty acids are emerging as bioactive agents protective against cardiovascular disease. However, their cellular delivery pathways are poorly defined. Here we questioned whether the uptake of n − 3 triglyceride-rich particles (TGRP) is mediated by cell surface proteoglycans (PG) using LDL receptor (LDLR)+/+ and LDLR−/− cell models. LDLR+/+ but not LDLR−/− cells showed higher n − 6 over n − 3 TGRP uptake. Removal of cell surface proteins and receptors by pronase markedly enhanced the uptake of n − 3 but not n − 6 TGRP. Lactoferrin blockage of apoE-mediated pathways decreased the uptake of n − 6 TGRP by up to 85% (p < 0.05) but had insignificant effect on n − 3 TGRP uptake. PG removal by sodium chlorate in LDLR+/+ cells substantially reduced n − 3 TGRP uptake but had little effect on n − 6 TGRP uptake. Thus, while n − 6 TGRP uptake is preferentially mediated by LDLR-dependent pathways, the uptake of n − 3 TGRP depends more on PG and non-LDLR cell surface anchoring.